AcroMetrix recently announced the release of the OptiQuant-S HCV RNA Quantification Panel
Many people in the medical community realize that viral Hepatitis B and C now make up more than 75% of all cases of liver disease around the world today and physicians rely on the accuracy of the viral load test provided to them by the laboratories to determine the amount of virus residing in the patient. These labs have recently been given a new tool to help improve accuracy and assist in the treatment of patients with the Hepatitis virus.
AcroMetrix recently announced the release of the OptiQuant-S HCV RNA Quantification Panel. This new panel uses AcroMetrix’s proprietary SynTuraÆTechnology and gives laboratories a vital component to fully optimize the Hepatitis C molecular assays available today.
AcroMetrix President and CEO, Michael J. Eck, said, “OptiQuant-S HCV represents our continued commitment to Hepatitis C diagnostic testing,” says Michael J. Eck, President and CEO. “Medical laboratories utilizing the new OptiQuant-S HCV Panel will experience the benefits of a standardized product that offers consistent results with an enhanced dynamic range; and as a result reducing patient re-testing requirements and increasing savings in both labor and reagent costs.”
What makes SynTuraÆspecial is that it involves a second generation viral RNA material that behaves in a similar manner to enveloped mammalian RNA viruses like HCV or HIV. Because of this new technology, synthetic sequences can be inserted into a mammalian RNA virus that’s shown to be stable in replication and capable of forming infectious RNase resistant virus particles. This exclusive system is useful for designing defined RNA positive controls, quantification standards, internal controls and calibrators. It should be noted that this product is designed to be used as a research-only tool and not for diagnostic procedures.
AcroMetrix has been a leader in the development of molecular products for years. They operate out of facilities located in Benicia, California and Alkmaar, the Netherlands. They provide a full-line of molecular diagnostic quality control products designed to help laboratories meet current government regulations. They’ve been able to maintain their position as a leader in the field by consistently developing innovative standards, external run controls and validation kits for molecular and serological testing in blood screening and clinical diagnostic laboratories.
If you’d like to learn more about the company, their products or their SynTuraÆTechnology, visit them at their website at www.acrometrix.com
Additional resources
AcroMetrix :: Home Page
AcroMetrix :: Article on Betaflow.com
AcroMetrix :: Listed on Review-inc.com
AcroMetrix:: Information on 800review.com
AcroMetrix:: Article on Incprofile.com
AcroMetrix :: Article on 4WorkLife.com